SXTC · China SXT Pharmaceuticals, Inc.

Summary

China SXT Pharmaceuticals, Inc. announced a registered direct offering of 2,000,000 Class A ordinary shares at $0.38 per share for gross proceeds of $760,000 via prospectus supplement.

Key takeaways

• Company to issue 2,000,000 Class A ordinary shares at $0.38 per share for $760,000 gross proceeds.
• Securities Purchase Agreement dated April 7, 2026 with multiple Purchasers.
• Closing via Delivery Versus Payment on or before second Trading Day after April 7, 2026.
• Appleby legal opinion confirms shares duly authorized, validly issued, fully paid, non-assessable under BVI law.
• No BVI stamp duties or withholding taxes on the offering.
• Shares subject to 9.99% beneficial ownership limitation per Purchaser.